Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage
-
Mauro Panteghini
Abstract
This paper presents evidence and suggestions from the IFCC Committee on “Standardization of Markers of Cardiac Damage” (C-SMCD) on the use of biochemical markers for the triage diagnosis of acute coronary syndromes. There is general agreement that both ‘early’ and ‘definitive’ biochemical markers of myocardial damage are necessary and that these assays must be available with a turnaround time of 1 h or less. Currently, myoglobin is the marker that most effectively fits the role as an ‘early’ marker, whereas ‘definitive’ markers are cardiac troponins. Since the sensitivity of the initial electrocardiogram is only 50 % for detecting myocardial infarction, the use of biochemical markers may significantly contribute to the early diagnosis and become relevant when the electrocardiogram is not diagnostic. In addition, new sensitive biochemical markers, particularly the cardiac troponins, are presently the best to detect the presence of minor myocardial cell damage. With regard to this, two decision limits are probably needed for the optimal use of troponins: a low abnormal value suggesting the presence of myocardial damage and a higher value suggesting the diagnosis of myocardial infarction according to traditionally used criteria. Properly designed studies should be performed to establish limits for each commercially available troponin assay. Finally, it is recognized that there is no need for the use of any biochemical marker when the clinical diagnosis is unequivocal, other than for diagnosing reinfarction, estimating the infarct size, and monitoring thrombolytic therapy.
Copyright © 1999 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Meetings and Awards
- Are Cardiac Troponins the Myocardial Markers for the New Millenium?
- Leukocyte Activation Markers in Clinical Practice
- Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level of Healthy, Anti-HCV-Negative Individuals
- Characterization of Monoclonal Antibodies to Human Protein 1/Clara Cell 10 Kilodalton Protein
- Rapid Analysis of Parathion in Biological Samples Using Headspace Solid-Phase Micro-Extraction (HS-SPME) and Gas Chromatography/Mass Spectrometry (GC/MS)
- Semi-Automated Rapid Isoelectric Focusing of Apolipoproteins C from Human Plasma Using PhastSystem™ and Immunofixation
- The c-erbB-2 Oncogene Amplification by Competitive PCR in Aneuploid Cell Clones Flow Sorted from Breast Cancer Samples
- The Index of Individuality Is Often a Misinterpreted Quantity Characteristic
- Assessment of Package Inserts for Diagnostic Kits
- External Quality Assessment in Clinical Chemistry: Review of the Situation in Croatia with Particular Reference to Equipment
- Point-of-Care Testing: the Views of the Working Group of the Dutch Association of Clinical Chemistry
- Preliminary Evaluation of the New Hematology Analyzer COULTER® GEN•S™ in a University Hospital
- Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage
- Oxidative Stress in Skeletal Muscle. A.E. Rezuick, L. Packer, C.K. Sen. J.O. Hollosey and M.J. Jackson, editors
- Handbook of Lipoprotein Testing. N. Rifai, C.G. Warnick and M.H. Dominiczak, editors
- Erratum: Matthias Oberhoffer, Heinz Vogelsang, Stefan Rußwurm, Thomas Hartung and Konrad Reinhart. Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis
Articles in the same Issue
- Meetings and Awards
- Are Cardiac Troponins the Myocardial Markers for the New Millenium?
- Leukocyte Activation Markers in Clinical Practice
- Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level of Healthy, Anti-HCV-Negative Individuals
- Characterization of Monoclonal Antibodies to Human Protein 1/Clara Cell 10 Kilodalton Protein
- Rapid Analysis of Parathion in Biological Samples Using Headspace Solid-Phase Micro-Extraction (HS-SPME) and Gas Chromatography/Mass Spectrometry (GC/MS)
- Semi-Automated Rapid Isoelectric Focusing of Apolipoproteins C from Human Plasma Using PhastSystem™ and Immunofixation
- The c-erbB-2 Oncogene Amplification by Competitive PCR in Aneuploid Cell Clones Flow Sorted from Breast Cancer Samples
- The Index of Individuality Is Often a Misinterpreted Quantity Characteristic
- Assessment of Package Inserts for Diagnostic Kits
- External Quality Assessment in Clinical Chemistry: Review of the Situation in Croatia with Particular Reference to Equipment
- Point-of-Care Testing: the Views of the Working Group of the Dutch Association of Clinical Chemistry
- Preliminary Evaluation of the New Hematology Analyzer COULTER® GEN•S™ in a University Hospital
- Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage
- Oxidative Stress in Skeletal Muscle. A.E. Rezuick, L. Packer, C.K. Sen. J.O. Hollosey and M.J. Jackson, editors
- Handbook of Lipoprotein Testing. N. Rifai, C.G. Warnick and M.H. Dominiczak, editors
- Erratum: Matthias Oberhoffer, Heinz Vogelsang, Stefan Rußwurm, Thomas Hartung and Konrad Reinhart. Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis
